TaiGen prepping NDA in China for antibiotic

TaiGen Biopharmaceuticals Holdings Ltd. (TPEx:4157) said IV nemonoxacin met the primary endpoint of clinical success rate in

Read the full 172 word article

How to gain access

Continue reading with a
two-week free trial.